,,ii #aae? ,,congress #b;d ,session ,s4 #bhhe ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,may #ag1 #bjah ,ms4 ,smi? introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ,bank+1 ,h\s+1 & ,urban ,affairs ,a ,,bill ,to am5d ! ,securities ,ex*ange ,act ( #aicd to require additional disclosure = ph>maceutical companies4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,disclos+ ,ph>maceutical ,company ,w9dfall ,pr(its ,act ( #bjah4 #b4 ,additional disclosure = ph>maceutical companies ,section #ac ( ! ,securities ,ex*ange ,act ( #aicd 7#ae ,u4,s4,c4 #ghm7 is am5d$ by add+ at ! end ! foll[+3 7s7 ,additional disclosure = ph>maceutical companies 7#a7 ,9 g5]al ,ea* issu] requir$ to file an annual or qu>t]ly report "u subsection 7a7 %all disclose 9 t report ! in=mation requir$ by p>agraph 7#b7 if1 dur+ ! p]iod cov]$ by ! report1 ! issu] or any affiliate ( ! issu] is a drug manufactur]4 7#b7 ,in=mation requir$ ,if an issu] or an affiliate ( ! issu] is requir$ to make a disclosure pursuant to p>agraph 7#a71 ! disclosure %all include-- 7,a7 a c\ntry-by-c\ntry report2 7,b7 a description ( any *ange 9 divid5d or *ange 9 %>e repur*ase plan aft] ,novemb] #b1 #bjag1 & ! total value ( su* *ange2 7,c7 bonuses or o!r *anges 9 comp5sation ( (fic]s or directors aft] ,novemb] #b1 #bjag1 & ! total value & p]c5tage *anges 9 comp>ison to ! prior ye>2 7,d7 ! total value ( ! rese>* & exp]im5tation tax cr$it 7pursuant to section #da ( ! ,int]nal ,rev5ue ,code ( #aihf7 claim$ by ! issu] or any affiliate = ! prec$+ tax ye>2 7,e7 ! *ange 9 sp5d+ on rese>* & developm5t ( prescription drugs1 includ+ an e/imate ( total value ( inve/m5t 9 rese>* & developm5t & ! total value ( any *ange 9 rese>* & developm5t = :i* ! *ange 0 pr9cipally ! result ( ,public ,law #aae-ig 7#aca ,/at4 #bjed72 7,f7 ! total am\nt (-- 7i7 def]r$ =eign income subject to m&atory inclusion pursuant to section #ife7;a7 ( ! ,int]nal ,rev5ue ,code ( #aihf2 & 7ii7 d$uctions all[able "u section #ife7;c7 ( su* ,code1 includ+ ! am\nt ( su* d$uctions attributable to ! #h p]c5t rate equival5t p]c5tage & ! am\nt attributable to ! #ae4e p]c5t rate equival5t p]c5tage2 7,g7 am\nts describ$ 9 section #afb7;e7 ( ! ,int]nal ,rev5ue ,code ( #aihf2 & 7,h7 any o!r mat]ial actions by ! issu] = :i* ! action 0 pr9cipally ! result ( ,public ,law #aae-ig 7#aca ,/at4 #bjed74 7#c7 ,=eign subsidi>ies ,= ea* =eign subsidi>y 9 ! c\ntry-by-c\ntry report1 ! report requir$ by p>agraph 7#a7 %all be gr\p$ by resid5t jurisdiction 7includ+ a gr\p = subsidi>ies resid5t n[h]e71 ! tax jurisdiction 7if diff]5t71 & ma9 bus9ess activity4 7#d7 ,def9itions ,9 ?is subsection3 7,a7 ,c\ntry-by-c\ntry report ,! t]m c\ntry-by-c\ntry report means in=mation on a c\ntry-by-c\ntry basis dur+ ! cov]$ p]iod = ea* tax jurisdiction1 aggregat$ f all subsidi>ies resid+ 9 t jurisdiction1 consi/+ (-- 7i7 rev5ues f unrelat$ p>ties1 relat$ p>ties1 & 9 total2 7ii7 pr(it or loss be=e taxes2 7iii7 income tax accru$ = ! curr5t ye>2 7iv7 income tax paid 7on a ca% basis72 7v7 /at$ capital2 7vi7 accumulat$ e>n+s2 7vii7 numb] ( employees2 7viii7 tangible assets o!r ?an ca% or ca% equival5ts2 & 7ix7 su* o!r f9ancial in=mation z ! ,commission may det]m9e is necess>y or appropriate 9 ! public int]e/ or = ! protection ( inve/ors4 7,b7 ,drug manufactur] ,! t]m drug manufactur] means ! p]son t holds ! application = a drug approv$ "u section #eje ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 or ! lic5se issu$ "u section #cea ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bfb74 4